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Abstract: Fructose ingestion is often associated with hepatic steatosis and hypertriglyceridemia. The homeostasis of hepatic lipids is
mainly determined by the interplay of lipogenesis and fatty acid β‑oxidation. In this study, we hypothesized that high fructose intake
disturbs hepatic lipid metabolism through an imbalance between these processes. Therefore, we analyzed the effects of a 9-weeklong consumption of a 60% fructose solution on physiological parameters, glycemia, and blood lipid profiles in male Wistar rats. The
expression of key regulators of fatty acid oxidation (FAO) and lipogenesis in the liver were assessed by western blot and quantitative
polymerase chain reaction. The results showed that fructose-fed rats were normoglycemic and hypertriglyceridemic with visceral
adiposity, but without hepatic lipid deposition. A high-fructose diet is associated with increased nuclear levels of the lipogenic regulator
sterol regulatory element binding protein 1c (SREBP-1c), which was followed by increased acetyl‑CoA carboxylase and fatty acid synthase
mRNAs. The nuclear level of the FAO transcriptional regulators peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1)
and lipin‑1 were unaltered, while carnitine palmitoyltransferase 1 (CPT1) mRNA was significantly decreased. Overall, our findings
showed that liquid fructose overconsumption is associated with perturbation of hepatic lipid metabolism through predominance of
lipogenesis over β-oxidation, resulting in spillover of triglycerides and visceral adiposity.
Key words: Dietary fructose, fatty acid oxidation, lipogenesis, liver, rat

1. Introduction
Numerous studies have reported that high dietary fructose
intake is associated with various adverse metabolic
disturbances in different animal models, including obesity,
hypertriglyceridemia, and insulin resistance (Rutledge
and Adeli, 2007; Dekker et al., 2010; Collison et al., 2011;
Newell-Fugate et al., 2014), which successfully mimic
nutrition-related disorders in the human population.
However, over the last decade a series of questions have
arisen regarding the role of fructose in the development
of the current epidemic of metabolic disorders (Tappy
and Mittendorfer, 2012). In addition, the mechanism
underlying the hyperlipidemic effects of fructose remains
controversial, since it appears that only a small percentage
of the ingested fructose in the human diet (<1%) is
directly converted to plasma triglycerides (Sun and
Empie, 2012). Whether fructose overconsumption will
lead to hypertriglyceridemia and hepatic steatosis depends
primarily on the balance between de novo lipogenesis
and fatty acid oxidation (Rebollo et al., 2014b). Rodent
models provide the most convenient way to investigate
* Correspondence: nvelickovic@ibiss.bg.ac.rs

the underlying molecular mechanism and to test potential
therapeutic interventions in the human population
(Panchal and Brown, 2011).
One of the master transcriptional regulators of fatty
acid oxidation is peroxisome proliferator‑activated
receptor α (PPARα), which acts as a cellular fatty acid
sensor (Moreno et al., 2010). Upon activation, PPARα
induces the expression of multiple genes encoding
proteins involved in the mitochondrial β-oxidation of fatty
acids (Minnich et al., 2001). The transcriptional activation
of target genes by PPARα requires the recruitment of
peroxisome proliferator-activated receptor γ coactivator
1α (PGC‑1α) (Vega et al., 2000) and lipin‑1, which acts
as an amplifier of the PPARα/PGC‑1α signaling system
(Finck et al., 2006). The nuclear PPARα/PGC‑1α/lipin‑1
complex stimulates the expression of genes involved in fatty
acid oxidation, including carnitine palmitoyltransferase
1 (CPT1) and medium chain acyl‑CoA dehydrogenase
(Leone et al., 1999). CPT1 represents a rate‑limiting
enzyme for β‑oxidation, a process that begins with the
transport of free fatty acids delivered from circulation
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into the mitochondria by a CPT1/CPT2 shuttle system
(Bonnefont et al., 2004). Interestingly, CPT1 activity is
inhibited by malonyl‑CoA, which is the product of the
enzyme acetyl‑CoA carboxylase (ACC) that catalyzes
the first reaction of de novo lipogenesis. Therefore,
reciprocal regulatory mechanisms have a crucial role in
maintaining a balance between the opposite processes of
lipid metabolism.
De novo lipogenesis in the liver is controlled by several
transcription factors, including sterol regulatory element
binding proteins (SREBPs) (Horton et al., 2002). SREBP‑1c
regulates triglyceride synthesis through the expression of
several downstream target genes, such as ACC, fatty acid
synthase (FAS), and stearoyl‑CoA desaturase 1 (SCD1)
(Horton et al., 2002). Subsequent studies implied that
fructose-induced triglyceride accumulation is a result of
de novo lipogenesis and that it is not driven by dietary lipid
uptake (Nunes et al., 2014). However, the development of
hepatic steatosis and hypertriglyceridemia depends not
only on lipogenesis but also on the fatty acid oxidation in
the liver. The importance of these processes in fructoseinduced metabolic disturbances is still unclear; therefore,
the aim of this study was to examine the effect of a high
fructose diet (60% fructose solution) on both β‑oxidation
and de novo lipogenesis in the livers of male Wistar rats.
Towards that end, we investigated hepatic lipid metabolism
by examining the expression of key proteins of fatty acid
β-oxidation (PPARα, PGC-1, nuclear lipin-1, CPT1) and
de novo lipogenesis (SREBP-1c, ACC, FAS). The blood
levels of free fatty acids (FFAs), triglycerides, and glucose,
as well as liver triglyceride levels, were also compared
between fructose‑fed rats and animals on a control diet.
2. Materials and methods
2.1. Animals and diet
Male Wistar rats aged 21 days, bred in our laboratory,
were randomly divided into two experimental groups
(n = 9 animals per group) according to diet regime for 9
weeks. The control group had standard laboratory chow
(Veterinary Institute, Subotica, Serbia) and drinking water
available ad libitum, while the fructose‑fed group was
given the same food with both a 60% fructose (API‑Pek,
Becej, Serbia) solution and drinking water ad libitum. The
detailed composition of the diet was published previously
(Velickovic et al., 2013). Drinking water was provided
for the fructose‑fed group in order to avoid possible
disturbances of the rats’ electrolyte–water balance. The
animals were kept in a temperature‑controlled room (22
± 2 °C) with a 12 h light/dark cycle (lights on at 0700
hours) and constant humidity. Daily food and fluid intake
were measured throughout the treatment. Total energy
intake was expressed as kJ per animal per day and was
calculated as previously reported (Vasiljevic et al., 2014).
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The protocols were in compliance with Directive 2010/63/
EU on the protection of animals used for experimental
and other scientific purposes and were approved by the
Ethics Committee for the Use of Laboratory Animals of
the Institute for Biological Research “Siniša Stanković”,
University of Belgrade (reference number 3-12/12).
2.2. Blood plasma preparation, tissue collection, and
determination of biochemical parameters
After overnight fasting, the animals were sacrificed by
decapitation with a guillotine (Harvard‑Apparatus, USA),
always at the same time (0900–1000 hours). Trunk blood
was rapidly collected into EDTA-containing tubes and the
glucose and triglyceride concentrations were measured
using a MultiCare apparatus with MultiCare glucose strips
(product code 23955) and MultiCare triglyceride strips
(product code 23960) (Biochemical Systems International,
Italy). Blood plasma was isolated by centrifugation at
1600 × g for 10 min at room temperature and stored at
–70 °C. Livers, perfused with cold 0.9% NaCl, and visceral
adipose tissue (retroperitoneal and omental depots) were
both carefully excised and kept in liquid nitrogen for
later RNA and protein isolation. Liver triglycerides were
isolated from 100 mg of liver tissue using a modified Folch
method (Folch et al., 1957) and analyzed with the modified
colorimetric method of Fletcher (Fletcher, 1968). FFA
plasma level was determined by using a modified version
of Duncombe’s (1964) method.
2.3. Preparation of cytoplasmic, nuclear, and whole-cell
extracts of the liver
Frozen livers from individual animals were weighed
and homogenized with a Janke–Kunkel Ultra-Turrax
in 4 volumes (w/v) of ice‑cold homogenization buffer
(20 mM Tris‑HCl, pH 7.2, 10% glycerol, 50 mM NaCl,
1 mM EDTA‑Na2, 1 mM EGTA‑Na2, 2 mM DTT, and
protease and phosphatase inhibitors). The homogenates
were further processed to obtain cytoplasmic and nuclear
fractions, as described previously (Vasiljevic et al., 2013).
All steps were conducted at 4 °C and all samples were
divided into aliquots and stored at –70 °C.
For preparation of whole-cell extracts, tissues were
homogenized with a glass–Teflon homogenizer in 5
volumes (w/v) of ice‑cold RIPA buffer (50 mM Tris‑HCl,
pH 7.2, 1 mM EDTA‑Na2, 150 mM NaCl, 0.1% SDS, 1%
Nonidet P‑40, 0.5% sodium deoxycholate, 2 mM DTT, and
protease and phosphatase inhibitors) and the homogenates
were sonicated (3 × 30 s, 1 A, 50/60 Hz). After 60 min of
incubation on ice with continuous agitation and frequent
vortexing, the suspensions were centrifuged (16000 × g, 20
min, 4 °C) and the resulting supernatants were divided into
aliquots, stored at –70 °C, and used as whole-cell extracts.
The protein content of all cellular fractions was
determined using Spector’s (1978) method with bovine
serum albumin as the standard.
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2.4. RNA isolation, reverse transcription, and real-time
PCR
Total RNA was extracted from the liver of each animal
using TRIreagent (AmBion Inc., Austin, TX, USA).
Quantitative and qualitative evaluation of the isolated
RNA was performed spectrophotometrically (OD 260/280
> 1.8 was considered satisfactory) and on 2% agarose gel.
Reverse transcription was performed using a high‑capacity
cDNA reverse transcription kit (Applied Biosystems)
according to the manufacturer’s instructions. The cDNAs
were stored at –70 °C for later use.
Quantification of target gene expression in the liver
was performed using TaqMan real-time polymerase
chain reaction (PCR) following a previously published
protocol (Djordjevic et al., 2012). The probe set used
for the quantification was ACC (Rn00573474_m1),
FAS (Rn 01463550_m1), and hypoxanthine-guanine
phosphoribosyltransferase (HPRT1; Rn01527840_m1*)
(Applied Biosystems Assay‑On‑Demand Gene Expression
Products). HPRT1 was used as an internal control for
quantitative normalization of cDNA.
2.5. Western blot analysis
After being boiled in Laemmli’s sample buffer, 40 µg of liver
protein was resolved on 7.5% or 10% SDS‑polyacrylamide
gels (samples to be compared were always run on the same
gel). The transfer of proteins from the gels to polyvinylidene
fluoride membranes (Immobilon‑FL, Millipore) was
done overnight at 135 mA and 4 °C in a transfer buffer
(25 mM Tris-HCl, pH 8.3, 192 mM glycine, and 20%
methanol). Membranes were incubated overnight at 4 °C
with the following rabbit polyclonal antibodies (all from
Santa Cruz Biotechnology): anti‑PPARα (sc‑9000, 1:250),
anti‑PGC‑1α (sc‑13067, 1:250), anti‑lipin‑1 (sc‑98450,

1:500), anti‑CPT1 (sc‑139482, 1:500), and anti‑SREBP‑1c
(sc‑366, 1:500). Mouse monoclonal anti‑β‑actin antibody
(AC‑15, Sigma‑Aldrich, 1:10000) was used for equal
load control. The membranes were incubated for 90
min with alkaline phosphatase conjugated secondary
antibodies (Amersham Pharmacia Biotech, 1:20,000).
Immunopositive bands were visualized using an enhanced
chemifluorescent method on the STORM 840 Gel and Blot
Imaging System (GE Healthcare) and quantified using
ImageQuant (GE Healthcare).
2.6. Statistical analyses
The data for energy intake as well as morphological and
biochemical parameters are given as mean ± SD (n = 9).
Real-time PCR and western blot data are presented as
mean ± SEM (n = 9). The normality of data distribution
was tested using the Shapiro–Wilk test. Between-group
comparisons were performed using the Student unpaired
t-test. Statistical analyses were performed using GraphPad
Prism v.5. Results were considered statistically significant
at P < 0.05.
3. Results
3.1. Effect of dietary fructose on energy intake; body, liver,
and adipose tissue masses; and biochemical parameters
Food intake was significantly lower (Table, P < 0.05)
while energy intake was higher for the fructose‑fed rats as
compared to the controls (Table, P < 0.01). No significant
between‑group differences in body and liver masses were
observed, but liver‑to‑body ratio was augmented in the
fructose‑fed rats. Moreover, rats consuming the fructose
solution showed increased absolute (Table, P < 0.05) and
relative (P < 0.05) visceral adipose tissue masses compared
to the controls. Long‑term consumption of the 60% fructose

Table. The effects of a fructose‑enriched diet on body, liver, and visceral adipose tissue (VAT)
masses, energy intake, and biochemical parameters. *P < 0.05, **P < 0.01.
Diet

Control

Fructose

P

Daily food intake (g/animal)

21.73 ± 0.73

16.99 ± 2.71*

0.034

Daily caloric intake (kJ/animal)

239.05 ± 8.05

324.4 ± 23.8**

0.003

Body mass (g)

333.50 ± 32.34

345.64 ± 32.95

0.435

Liver mass (g)

11.37 ± 1.57

12.80 ± 1.40

0.064

Liver-to-body ratio (×1000)

34.00 ± 1.98

37.05 ± 3.21*

0.021

VAT mass (g)

4.37 ± 1.73

6.26 ± 1.62*

0.039

VAT-to-body ratio (×1000)

13.26 ± 5.10

18.21 ± 4.64*

0.049

Glucose (mmol/L)

4.08 ± 0.30

3.88 ± 0.24

0.157

Triglycerides (mmol/L)

1.13 ± 0.25

1.55 ± 0.32**

0.006

FFAs (mmol/L)

0.69 ± 0.18

0.70 ± 0.32

0.901

Triglycerides in the liver (mmol/L)

1.37 ± 0.70

1.20 ± 0.31

0.392
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solution led to a significant increase in triglyceride levels
in the blood (Table, P < 0.01), while plasma glucose and
FFA levels remained unchanged after the high-fructose
diet (Table). In addition, the liver triglycerides were not
different between the two groups (Table).
3.2. Lipid metabolism in the livers of fructose‑fed rats
To evaluate the effects of the fructose solution on the key
regulators of lipid metabolism in the liver, we analyzed the
concentration and cytoplasmic/nuclear redistribution of
proteins involved in the regulation of mitochondrial fatty
acid β‑oxidation and de novo lipogenesis. We observed
that 60% fructose consumption led to a significant
decrease of PPARα in the cytoplasmic fraction (Figure
1a, P < 0.001) and a concomitant elevation in the nuclear
fraction (Figure 1b, P < 0.01). The analysis of PGC‑1α
intracellular redistribution showed that its cytoplasmic
level was decreased (Figure 2a, P < 0.05), while its nuclear
level remained unchanged (Figure 2b). Concomitantly,
the levels of another transcription cofactor involved in
β‑oxidation, lipin‑1, were unaltered in the cytoplasmic
and nuclear fractions of the livers of fructose‑fed animals
(Figures 3a and 3b). Since nuclear accumulation of
PGC‑1α and lipin‑1 can enforce the transcription of the
CPT1 gene, the observation that a fructose diet did not
affect the nuclear levels of these proteins is in accordance
with the finding of decreased CPT1 protein levels in the
livers of fructose‑fed animals (Figure 4, P < 0.05).
a)

C

When we examined the key hepatic lipogenic
transcription factor SREBP‑1c, we noticed a significant
increase in its nuclear concentration (Figure 5a, P <
0.05). Furthermore, the mRNA level of SREBP‑1c target
genes ACC and FAS were also increased in the livers of
fructose‑fed rats (Figures 5b and 5c, P < 0.05).
4. Discussion
In the present study, we examined the effects of high dietary
fructose (60% solution) on the development of metabolic
syndrome features and on hepatic lipid metabolism in a
rodent model. The results demonstrated that rats exposed
to a fructose‑enriched diet were hypertriglyceridemic and
normoglycemic, with no significant differences in body
and liver masses in comparison to the controls; however,
these animals showed signs of increased visceral adiposity
and augmented liver-to-body ratio. These metabolic
alterations most likely resulted from the simultaneous
induction of hepatic lipogenic factors SREBP‑1c, ACC,
and FAS, and the inhibition of mitochondrial β‑oxidation.
In spite of the decreased fatty acid oxidation nuclear
PPARα was increased, implying that it has a role in
hepatic lipogenesis. The alleviation of fructose-induced
metabolic disturbances could be achieved by the use of
pharmacological stimulators of fatty acid oxidation.
In our study, caloric intake was higher for the fructosefed rats, but both body weight and liver mass were
b)

F

C

PPAR α

PPAR α

β -a c tin

β -a c tin

1.5

Cytoplasmic fraction

Nuclear fraction

2.5

**

***

0.5

PPAR α protein
(fold change)

PPAR α protein
(fold change)

2
1

F

1.5
1
0.5
0

0
C

F

C

F

Figure 1. Subcellular distribution of PPARα protein in the liver after a fructose‑rich diet. Representative western blots and relative
quantification of the PPARα protein are shown in the hepatic cytoplasmic (a) and nuclear (b) fractions of the control (C) and
fructose‑fed (F) rats. The lower parts of the blots were probed with antibodies against β‑actin, which was used as a loading
control. Values are means ± SEM and are presented as folds of the control (n = 9). Comparisons between the groups were made
using an unpaired Student t-test. Asterisks indicate significant differences, **P < 0.01 and ***P < 0.001.
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a)

C

b)

F

C

PGC -1α

PGC -1α

β -a c tin

β -actin
Cytoplasmic fraction

1

*
0.5

0

C

Nuclear fraction

2.5
PGC -1α protein
(fold change)

PGC -1α protein
(fold change)

1.5

F

2

1.5
1
0.5
0

F

C

F

Figure 2. Subcellular distribution of PGC‑1 protein in the liver after a fructose‑rich diet. Representative western blots and
relative quantification of the PGC‑1 protein are shown in the hepatic cytoplasmic (a) and nuclear (b) fractions of the control (C)
and fructose‑fed (F) rats. The lower parts of the blots were probed with antibodies against β‑actin, which was used as a loading
control. Values are means ± SEM and are presented as folds of the control (n = 9). Comparisons between the groups were made
using an unpaired Student t-test. Asterisks indicate a significant difference, *P < 0.05.

a)

C

b)

F

C

Lipin -1

Lipin -1

β -actin

β -actin
Cytoplasmic fraction

Nuclear fraction

2

1.5

Lipin -1 protein
(fold change)

Lipin -1 protein
(fold change)

2

1
0.5
0

F

1.5
1
0.5
0

C

F

C

F

Figure 3. Subcellular distribution of lipin‑1 protein in the liver after a fructose‑rich diet. Representative western blots and relative
quantification of the lipin‑1 protein are shown in the hepatic cytoplasmic (a) and nuclear (b) fractions of the control (C) and
fructose‑fed (F) rats. The lower parts of the blots were probed with antibodies against β‑actin, which was used as a loading
control. Values are means ± SEM and are presented as folds of the control (n = 9). Comparisons between the groups were made
using an unpaired Student t-test.

unaffected by the applied diet regime, which is consistent
with the results obtained from another animal study using
a 60% fructose diet (Kelley et al., 2004). The fructose-fed

group had signiﬁcantly increased adipose tissue mass and
a higher visceral adipose tissue-to-body ratio, pointing
to visceral adiposity. The liver-to-body ratio was also
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increased in the fructose-fed animals; however, this was
not accompanied by an accumulation of triglycerides in
the liver. The hypertriglyceridemia observed in the 60%
fructose-fed animals represents a metabolic hallmark of
fructose-enriched diets (Roglans et al., 2007; Rebollo et
al., 2014a). This was not associated with increased plasma
FFA levels, which is in accordance with some other studies
(Roglans et al., 2002; Menard et al., 2010). It is well known
that hepatic production of very‑low‑density lipoproteins
(VLDLs) is primarily responsible for hypertriglyceridemia
(Wang et al., 1984) and that the main regulator of
hepatic lipogenesis is SREBP-1c, which acts through
transcriptional control of ACC and FAS. In this study, we
detected an increased level of active SREBP‑1c followed by
enhanced ACC and FAS gene expression. Taken together,
these results point toward increased de novo lipogenesis,
presumably due to the accumulation of lipogenic
precursors upon high fructose consumption. On the other
hand, mitochondrial fatty acid β‑oxidation was inhibited,
as judged by the significantly decreased CPT1 level in
the whole-cell extract. This is probably due to higher
ACC expression that could lead to increased production
of malonyl‑CoA, which is an inhibitor of CPT1 and
consequently of fatty acid oxidation (Rodriguez-Calvo et
al., 2009). However, in spite of the reduced β‑oxidation, we
observed increased levels of nuclear PPARα protein, which
can be explained by the fact that PPARα is also involved in
the regulation of hepatic lipid metabolism apart being a

F

CPT1
β -actin
Whole-cell extract

CPT1 protein
(fold change)

1.5

1

*

0.5

0

C

F

Figure 4. The effect of a fructose‑rich diet on CPT1 protein level in
the liver. Representative western blots and relative quantification
of the CPT1 protein are shown in the whole-cell extract of the
livers of the control (C) and fructose‑fed (F) rats. The lower parts
of the blots were probed with antibody against β‑actin, which
was used as a loading control. Values are means ± SEM and are
presented as folds of the control (n = 9). Comparisons between
the groups were made using an unpaired Student t-test. Asterisks
indicate a significant difference, *P < 0.05.

b)
C

F

SREBP -1c
β -actin

SREBP -1c protein
(fold change)

2.5

Nuclear fraction

2

*

1.5
1
0.5
0
C

F

c)

FAS mRNA (fold change)

a)

ACC mRNA (fold change)

2

*

1.5
1
0.5
0
2

C

F

*

1.5
1
0.5

0
C

F

Figure 5. The effect of a fructose‑rich diet on SREBP‑1c protein level and gene expression of ACC and FAS in the liver. Representative
western blots and relative quantification of the SREBP‑1c protein are shown in the hepatic nuclear fractions of the control (C) and
fructose‑fed (F) rats. Lower parts of the blots were probed with antibody against β‑actin, which was used as a loading control (a).
Relative quantification of ACC (b) and FAS (c) mRNA levels in the livers were done relative to the amount of HPRT1 mRNA. Values are
means ± SEM and are presented as folds of the control (n = 9). Comparisons between the groups were made using an unpaired Student
t-test. Asterisks indicate a significant difference, *P < 0.05.
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regulator of fatty acid oxidation (Oosterveer et al., 2009).
Namely, increased PPARα activity was shown to enhance
the flux of fatty acids from the adipose tissue to the liver via
stimulation of fibroblast growth factor 21 gene expression
(Inagaki et al., 2007), thus maintaining circulating FFA
concentrations at a constant level. Moreover, PPARα seems
to be a transcriptional activator of SREBP‑1c (FernandezAlvarez et al., 2011) and SCD1 (Miller and Ntambi, 1996),
two main promoters of de novo lipogenesis. Since in
this study we observed an increased expression of active
SREBP‑1c and FAS in the livers of the fructose-fed rats
as well as an unchanged level of plasma FFAs, we suggest
that the hepatic PPARα activation in these animals was
predominantly associated with stimulated lipogenesis
(Chakravarthy et al., 2005).
The expected outcome of enhanced de novo
lipogenesis should be a high rate of triglyceride secretion
in the form of VLDLs or the ectopic accumulation of
lipids in the hepatocytes (Kawano and Cohen, 2013).
In the present study, 60% fructose consumption was
found to be associated with hypertriglyceridemia. On
the other hand, we did not observe excessive triglyceride
accumulation in the liver, which is in accordance with the
results of other animal studies using a 60% fructose diet
(Kelley et al., 2004; de Moura et al., 2009). According to

these results, we presume that the hepatic overproduction
of triglyceride-rich lipoproteins due to a liquid highfructose diet is channeled into secretory pathways instead
of being accumulated in the liver, resulting in excessive
visceral adiposity (Sam et al., 2009) and an increased risk
of metabolic complications (Lemieux et al., 2007). The
observed hypertriglyceridemia without concomitant signs
of hepatic steatosis may merely reflect an adaptation to a
high-fructose diet (Tappy and Le, 2015) that still has not
progressed to pathological status.
In summary, the results of the present study indicate
that consumption of 60% fructose solution disturbs
hepatic lipid metabolism by simultaneously inducing de
novo lipogenesis and inhibiting fatty acid β‑oxidation, thus
resulting in hypertriglyceridemia and visceral adiposity,
but without ectopic hepatic lipid deposition. Future
longitudinal studies are required to elucidate the timing
of hepatic mitochondrial dysfunction and lipogenesis
in relation to fructose‑induced metabolic syndrome
development.
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